Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “TAM”

Showing 7 of 0 results

Not applicableLooking for participantsNCT07808164
What this trial is testing

ENPP1/cGAS (EG) and FAP Expression Profiles in Solid Tumors: An Immunohistochemical Study in a Vietnamese Cohort

Who this might be right for
HCC - Hepatocellular CarcinomaCRC (Colorectal Cancer)Gastric Carcinoma+5 more
Tam Anh Research Institute 162
Not applicableNot Yet RecruitingNCT07381205
What this trial is testing

Assessing the Incidence of Transplant Associated Thrombotic Microangiopathy (TA-TMA) in Adult Patients Undergoing Allogeneic Stem Cell Transplant (SCT)

Who this might be right for
Transplant Associated Microangiopathy TAMTransplant Complication
Manuel Ricardo Espinoza-Gutarra 85
Testing effectiveness (Phase 2)Ended earlyNCT02322853
What this trial is testing

Trial Assessing the Efficacy and Safety of tamOxifen Plus LY2228820 in Advanced or Metastatic Breast Cancer Progressing on aromatasE Inhibitors

Who this might be right for
PostmenopausalMetastatic Breast Cancer
Centre Francois Baclesse 8
Not applicableStudy completedNCT00959283
What this trial is testing

Study of Blood Samples From Newborns With Down Syndrome

Who this might be right for
Myeloid Proliferations Associated With Down Syndrome
Children's Oncology Group 180
Large-scale testing (Phase 3)Study completedNCT00849030
What this trial is testing

ATAC - Arimidex, Tamoxifen Alone or in Combination

Who this might be right for
Breast Cancer
AstraZeneca 9,358
Testing effectiveness (Phase 2)Study completedNCT03346200
What this trial is testing

Low Dose Tamoxifen for Mammographic Density Reduction

Who this might be right for
Risk ReductionMammographic Density Reduction
Per Hall 1,440
Not applicableStudy completedNCT01341171
What this trial is testing

The Impact of Tamoxifen and Aromatase Inhibitors on Platelet Proteins

Who this might be right for
Breast Cancer
University of Vermont 30

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation